The prognosis of multiple myeloma is usually based on the existence of different signs, symptoms, and circumstances. Multiple myeloma prognosis as well as survival rates have improved due to myeloma research. The prognosis of myeloma is also dependent on the stage of the disease as determined by the results of diagnostic testing. Survival rates are sometimes used by doctors to explain a patient’s prognosis; however, many patients prefer to avoid knowing about myeloma survival rates when learning of their prognosis.
In arriving at prognosis for multiple myeloma, several clinical and laboratory findings provide important information. These prognostic indicators help determine how fast the tumor is growing, the extent of disease, the biologic make-up of the tumor, the response to therapy, and the overall health status of the individual. Prognostic indicators may also help determine whenmultiple myeloma treatment should begin, and which treatment is best according to a person’s individual risk for relapse.